Govt says no need to panic over need for immediate change in dosage interval of Covishield

Covishield produces more antibodies than Covaxin, finds study

‘Same rules for all’: Serum Institute seeks indemnity protection

K’taka’s global tender for vaccines get response from 2 firms to supply Sputnik

Karnataka receives 3 lakh Covishield vaccines from Centre

Wastage of Covaxin down to 4% from 17% in March and Covishield from 8% to 1%: Govt

Karnataka receives 2,00,000 doses of Covishield: Dr K Sudhakar

Booster effect even at six months, don’t worry: experts on Covishield dose gap

Govt asks people to not visit vaccination centres before 12 weeks of Covishield jab

Gap between two doses of Covishield extended from 6-8 weeks to 12-16 weeks: Govt

Govt panel suggests increasing gap between two doses of Covishield

70 per cent Covishield stock for vaccination of 45-plus age- group due for 2nd dose in K’taka

SC directs Centre to revisit current vaccine policy, says it may create disparity

Will return to India in a few days, says Adar Poonawalla

Over 79L COVID-19 vaccine doses available with States/UTs, says Centre

‘Indian strain’ of SARS-CoV-2 spreads faster, but little evidence of it being more lethal, say experts

US to immediately provide raw materials required for manufacturing Covishield in India; sending life-saving supplies

Serum Institute defends vaccine pricing, says initial rates based on advance funding

Karnataka to purchase 1 crore doses of Covishield vaccine for Rs 400 crore

Over 21k tested positive for COVID after taking first dose of either Covishield or Covaxin: Govt

Congress demands one nation, one price for COVID vaccines

Serum prices COVID vaccine for pvt hospitals at Rs 600/dose; for state govts at Rs 400/dose

SII CEO urges US to lift raw material export ban to ramp up vaccine production

7 blood clot deaths after 18.1 mn jabs, AstraZeneca vaccine safe, states UK regulator

DCGI extends shelf life of Covishield from 6 to 9 months

Serum Institute seeks govt’s intervention over import of COVID vaccine raw material from US

Bharat Biotech’s Covaxin 81 pc efficient in Phase 3 trials

Over 8.25L vaccinated in Karnataka so far reports Health Dept

Man from Chikkaballapur dies nine days after receiving Covishield jab

18-19 anti-COVID-19 vaccines in pipeline says Health Min Vardhan

25 countries in queue for “Made In India” COVID-19 vaccine says EAM

Second dose of anti-COVID-19 vaccine to be administered to healthcare workers from Feb 13

PM-CARES Fund to foot over 80% cost of 1st phase of COVID vaccination drive

Relief for SII as court rejects trademark-violation plea over ‘Covishield’

Latest Additions

Four-day market rally makes investors richer by Rs 8.48 lakh crore

“Modi & Shah are sellers and Ambani-Adani are buyers”: Kharge’s sharp attack on BJP-led Centre

Uddhav fires ‘Bogus Janata Party’ barb at BJP over ‘nakli’ Shiv Sena jibe

Deve Gowda slams Rahul Gandhi over ‘wealth redistribution’ promise

LS Polls 2024: Nitin Gadkari faints during campaign rally in Yavatmal

Thanks for visiting Udayavani

You seem to have an Ad Blocker on.
To continue reading, please turn it off or whitelist Udayavani.